相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Prime-boost vectored malaria vaccines Progress and prospects
Adrian V. S. Hill et al.
HUMAN VACCINES (2010)
CD8+ T Cell Responses following Replication-Defective Adenovirus Serotype 5 Immunization Are Dependent on CD11c+ Dendritic Cells but Show Redundancy in Their Requirement of TLR and Nucleotide-Binding Oligomerization Domain-Like Receptor Signaling
Ross W. B. Lindsay et al.
JOURNAL OF IMMUNOLOGY (2010)
A Phase 1/2 Study of a Multiclade HIV-1 DNA Plasmid Prime and Recombinant Adenovirus Serotype 5 Boost Vaccine in HIV-Uninfected East Africans (RV 172)
Hannah Kibuuka et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Comparative Cell-Mediated Immunogenicity of DNA/DNA, DNA/Adenovirus Type 5 (Ad5), or Ad5/Ad5 HIV-1 Clade B gag Vaccine Prime-Boost Regimens
David M. Asmuth et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Vector Choice Determines Immunogenicity and Potency of Genetic Vaccines against Angola Marburg Virus in Nonhuman Primates
Thomas W. Geisbert et al.
JOURNAL OF VIROLOGY (2010)
Priming Immunization with DNA Augments Immunogenicity of Recombinant Adenoviral Vectors for Both HIV-1 Specific Antibody and T-Cell Responses
Richard A. Koup et al.
PLOS ONE (2010)
Safety and Immunogenicity of a Replication-Defective Adenovirus Type 5 HIV Vaccine in Ad5-Seronegative Persons: A Randomized Clinical Trial (HVTN 054)
Laurence Peiperl et al.
PLOS ONE (2010)
Prospects for immunisation against Marburg and Ebola viruses
Thomas W. Geisbert et al.
REVIEWS IN MEDICAL VIROLOGY (2010)
Stabilizing formulations for inhalable powders of an adenovirus 35-vectored tuberculosis (TB) vaccine (AERAS-402)
Tom H. Jin et al.
VACCINE (2010)
A replication defective recombinant Ad5 vaccine expressing Ebola virus GP is safe and immunogenic in healthy adults
J. E. Ledgerwood et al.
VACCINE (2010)
International epidemiology of human pre-existing adenovirus (Ad) type-5, type-6, type-26 and type-36 neutralizing antibodies: Correlates of high Ad5 titers and implications for potential HIV vaccine trials
T. Christopher Mast et al.
VACCINE (2010)
Safety and Immunogenicity of the Merck Adenovirus Serotype 5 (MRKAd5) and MRKAd6 Human Immunodeficiency Virus Type 1 Trigene Vaccines Alone and in Combination in Healthy Adults
Clayton Harro et al.
CLINICAL AND VACCINE IMMUNOLOGY (2009)
New Insights on Adenovirus as Vaccine Vectors
Marcio O. Lasaro et al.
MOLECULAR THERAPY (2009)
Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys
Jinyan Liu et al.
NATURE (2009)
Correlates of protective immunity for Ebola vaccines: implications for regulatory approval by the animal rule
Nancy J. Sullivan et al.
NATURE REVIEWS MICROBIOLOGY (2009)
Heterologous prime/boost immunizations of rhesus monkeys using chimpanzee adenovirus vectors
Sampa Santra et al.
VACCINE (2009)
Evaluation of a prime-boost vaccine schedule with distinct adenovirus vectors against malaria in rhesus monkeys
Arine Rodriguez et al.
VACCINE (2009)
Magnitude and phenotype of cellular immune responses elicited by recombinant adenovirus vectors and heterologous prime-boost regimens in rhesus monkeys
Jinyan Liu et al.
JOURNAL OF VIROLOGY (2008)
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial
Susan P. Buchbinder et al.
LANCET (2008)
Adenovirus 5 and 35 vectors expressing Plasmodium falciparum circumsporozoite surface protein elicit potent antigen-specific cellular IFN-γ and antibody responses in mice
Joseph P. Shott et al.
VACCINE (2008)
High-level expression from two independent expression cassettes in replication-incompetent adenovirus type 35 vector
Ronald Vogels et al.
JOURNAL OF GENERAL VIROLOGY (2007)
Clustal W and clustal X version 2.0
M. A. Larkin et al.
BIOINFORMATICS (2007)
Protective immune responses to a recombinant adenovirus type 35 tuberculosis vaccine in two mouse strains: CD4 and CD8 T-cell epitope mapping and role of gamma interferon
Katarina Radosevic et al.
INFECTION AND IMMUNITY (2007)
Myeloid and plasmacytoid dendritic cells are susceptible to recombinant adenovirus vectors and stimulate polyfunctional memory T cell responses
Karin Lore et al.
JOURNAL OF IMMUNOLOGY (2007)
Effect of preexisting immunity to adenovirus human serotype 5 antigens on the immune responses of nonhuman primates to vaccine regimens based on human- or chimpanzee-derived adenovirus vectors
Kimberly McCoy et al.
JOURNAL OF VIROLOGY (2007)
Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and D
Peter Abbink et al.
JOURNAL OF VIROLOGY (2007)
Mechanism of Ad5 vaccine immunity and toxicity: Fiber shaft targeting of dendritic cells
Cheng Cheng et al.
PLOS PATHOGENS (2007)
Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 candidate vaccine delivered by a replication-defective recombinant adenovirus vector
Andrew T. Catanzaro et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Immunogenicity of heterologous recombinant adenovirus prime-boost vaccine regimens is enhanced by circumventing vector cross-reactivity
Anna R. Thorner et al.
JOURNAL OF VIROLOGY (2006)
Intradermal delivery of adenoviral type-35 vectors leads to high efficiency transduction of mature, CD8+ T cell-stimulating skin-emigrated dendritic cells
Tanja D. de Gruijl et al.
JOURNAL OF IMMUNOLOGY (2006)
Novel replication-incompetent adenoviral B-group vectors: high vector stability and yield in PER.C6 cells
M. Havenga et al.
JOURNAL OF GENERAL VIROLOGY (2006)
Amine reactive dyes: An effective tool to discriminate live and dead cells in polychromatic flow cytometry
Stephen P. Perfetto et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2006)
Immune protection of nonhuman primates against Ebola virus with single low-dose adenovirus vectors encoding modified GPs
Nancy J. Sullivan et al.
PLOS MEDICINE (2006)
Immunogenicity and protection of a recombinant human adenovirus serotype 35-based malaria vaccine against Plasmodium yoelii in mice
OJAE Ophorst et al.
INFECTION AND IMMUNITY (2006)
Immunogenicity of recombinant fiber-chimeric adenovirus serotype 35 vector-based vaccines in mice and rhesus monkeys
A Nanda et al.
JOURNAL OF VIROLOGY (2005)
Immunogenicity of heterologous prime-boost regimens involving recombinant adenovirus serotype 11 (Ad11) and Ad35 vaccine vectors in the presence of anti-Ad5 immunity
AAC Lemckert et al.
JOURNAL OF VIROLOGY (2005)
Replication-defective adenovirus serotype 5 vectors elicit durable cellular and humoral immune responses in nonhuman primates
S Santra et al.
JOURNAL OF VIROLOGY (2005)
A large outbreak of acute encephalitis with high fatality rate in children in Andhra Pradesh, India, in 2003, associated with Chandipura virus
BL Rao et al.
LANCET (2004)
Adenovirus types 5 and 35 seroprevalence in AIDS risk groups supports type 35 as a vaccine vector
S Kostense et al.
AIDS (2004)
Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunity
DH Barouch et al.
JOURNAL OF IMMUNOLOGY (2004)
Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates
NJ Sullivan et al.
NATURE (2003)
Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination:: Efficient human cell infection and bypass of preexisting adenovirus immunity
R Vogels et al.
JOURNAL OF VIROLOGY (2003)
Quantifying adenovirus-neutralizing antibodies by luciferase transgene detection: Addressing preexisting immunity to vaccine and gene therapy vectors
MC Sprangers et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2003)
Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity
JW Shiver et al.
NATURE (2002)
Development of a preventive vaccine for Ebola virus infection in primates
NJ Sullivan et al.
NATURE (2000)
Re-emergence of vesicular stomatitis in the western United States is associated with distinct viral genetic lineages
LL Rodriguez et al.
VIROLOGY (2000)
分享论文
